iShares Biotechnology ETF (NASDAQ:IBB) Stock Cross Above Fifty Day Moving Average – What’s Next?

iShares Biotechnology ETF (NASDAQ:IBB) passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $207.81 and traded as high as $210.01. iShares Biotechnology ETF shares last traded at $208.69, with a volume of 765,470 shares changing hands.

iShares Biotechnology ETF Stock Performance

The stock’s 50 day simple moving average is $207.81 and its 200-day simple moving average is $183.96.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were paid a $0.0112 dividend. The ex-dividend date of this dividend was Tuesday, September 15th. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a dividend yield of 0.0%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in IBB. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at $550,000. Black Diamond Financial LLC purchased a new position in iShares Biotechnology ETF in the third quarter valued at $222,000. Oppenheimer & Co. Inc. grew its stake in iShares Biotechnology ETF by 42.4% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 32,080 shares of the financial services provider’s stock worth $6,754,000 after purchasing an additional 9,552 shares in the last quarter. Odyssey Capital Advisors Inc. grew its stake in iShares Biotechnology ETF by 7.5% during the 3rd quarter. Odyssey Capital Advisors Inc. now owns 5,585 shares of the financial services provider’s stock worth $1,176,000 after purchasing an additional 388 shares in the last quarter. Finally, Flagship Harbor Advisors LLC grew its stake in iShares Biotechnology ETF by 20.0% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 7,691 shares of the financial services provider’s stock worth $1,619,000 after purchasing an additional 1,284 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.